Clinical study evaluates safety and efficacy of methylone in patients with severe PTSD

Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase 2 study evaluating the safety and efficacy of methylone in patients with severe PTSD.

Lutris wins FDA orphan drug tag for EGFR inhibitor-induced rash candidate – Pharmaceutical Technology

Share this article According to Lutris’ CEO, approximately 75% of cancer patients taking EGFR inhibitors develop some form of acneiform rash. Credit: sruilk via Getty

February 29, 2024

3M reaches $6B settlement to resolve combat earplug lawsuits

Dive Brief: 3M has agreed to pay $6 billion to settle more than 250,000 lawsuits brought by U.S. military service members who allegedly suffered hearing

August 29, 2023

Michigan Cannabis Sales Slow Again

Michigan cannabis sales for May fell sequentially on a per-day basis as they increased just 0.4% from April. At $279.6 million, sales were up 13.7% from a

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.